16 January 2018
News and Views
Links and Services
A study in June's issue of the Alimentary Pharmacology & Therapeutics investigates the impact of mesalazine on disease-specific health-related quality of life in ulcerative colitis patients.
Past studies with ulcerative colitis patients indicate that disease activity strongly predicts he
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors